Book a Demo

Life Sciences

A New Dawn on Digital Transformation

                                                                                                                                                                              Download Digital Copy


Life science companies are on a mission to bring life-saving drugs to market as quickly and safely as possible. Yet, doing so is an expensive, time-consuming endeavor that may or may not result in a medication becoming commercially available.

But intelligent data does not exist solely at the ingestion phase. It includes information flowing into, through, and out of the business, with the ultimate goal of boosting time-to-market and increasing profitability.


  • Get drugs to market quickly and safely.
  • Streamline and automate collaboration between internal and external partners.
  • Ensure complete transparency and documentation.
  • Manage risks associated with mergers and acquisitions (M&A): buying or selling compounds
    or companies, and the complexity of ingesting key content

Don’t Be Burdened by Fear Dissecting all the things that can go wrong for life sciences companies is daunting. From compiling clean, submission-ready documents that adhere to stringent FDA regulations to distributing life-saving medicines through complex supply chains, pharma companies may expose themselves to vulnerabilities including:

  1. Controlling personally identifiable information (PII)
  2. Addressing supply chain complexity
  3. Managing global contract research organization (CRO) partnerships

Solution Document Processing Automation Powered by Content Intelligence

Pharmaceuticals and Life Sciences companies that invest in Content Intelligence are already reaping the benefits. Here’s how:

  • Adlib’s automated and scalable solution creates fully compliant documents to accelerate review and approval. The result: 100% of Adlib’s clients are FDA and EMA compliant.
  • Adlib is architected to operate day in and day out without faltering, regardless of load or complexity. The result: A leading pharmaceutical company experienced 99.9 percent uptime for mission-critical processing
  • Accelerating time-to-value to newly acquired assets has a significant impact on the speed with which new, potentially life-saving compounds can be brought to market. The result: Four times faster ingestion of M&A content.

Adlib’s Content Intelligence solution leverages artificial intelligence (AI), machine learning (ML), and natural language processing (NLP). It elaborates on IDP and other complimentary technology solutions with discovery analysis, duplicate detection and removal, more advanced classification, and other capabilities like signature detection. The platform reviews, sorts, filters, and validates classified content and delivers it to multiple ecosystems, including content services, RPA, insight engines, and business process management (BPM)systems. Companies spark innovation, gain market share, and deepen customer loyalty across industries.

Accelerate Time to Market with Adlib

In the face of unstructured data, digital transformation feels like a mirage in the desert, a place that’s always out of reach. With the right Content Intelligence solution, enterprises can reach greater ROI on their digital transformation investments faster. By addressing the unstructured data dilemma, Intelligent Document Processing powered by Content Intelligence brings agility to every person, every process, and every facet of data and document management—so you can soar above the “fast caterpillars” and become a truly digital enterprise.